Stephen Chan in

Stephen Chan

Login to view DISC.
Vice President - Clinical Data Science, Analytics, & Systems at REVOLUTION Medicines
📍 Cupertino, California, United States

Stephen Chan is the Vice President of Clinical Data Science, Analytics, & Systems at REVOLUTION Medicines, specializing in building high-performing teams for regulatory submissions. A UC Berkeley graduate with a SAS certification, he has led teams through the successful FDA approvals of major oncology drugs Imbruvica and Calquence. Colleagues describe him as creative, adaptive, and hard-working.

He led the statistical programming teams responsible for the successful FDA approvals of two major oncology drugs, Imbruvica and Calquence.

Read the full overview →
Experience
30 Years
Current Role
Vice President - Clinical Data Science, Analytics, & Systems
Job Level
Senior
Location
Cupertino, California, United States
Personality Overview

How Stephen shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Stephen cares about

Building Data Teams
Focuses on building efficient, well-balanced teams from the ground up, with an expertise in identifying and mentoring clinical data leaders.
Oncology Drug Approval
Has extensive experience leading teams through the successful FDA submission and approval process for major oncology drugs like Calquence and Imbruvica.
+4 more topics Login to view topics
Career

Work history

9-2021
Vice President - Clinical Data Science, Analytics, & Systems
REVOLUTION Medicines
5-2018 - 9-2021
Executive Director - Clinical Data Management, Statistical Programming, & Clinical Systems
REVOLUTION Medicines
11-2016 - 5-2018
Senior Director, Bioinformatics Application Development
Acerta Pharma B.V.
11-2014 - 11-2016
Senior Director and Head of Statistical Programming
Acerta Pharma B.V.
9-2011 - 10-2014
Associate Director, Statistical Programming
Pharmacyclics
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Bachelor's
University of California, Berkeley
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other REVOLUTION Medicines Employees

Explore more public profiles from related professionals.

Katie Ditmore Sinaikin
Katie Ditmore Sinaikin
Executive Director, Global Analytics and Insights
Revolution Medicines
 Camellia Lock
Camellia Lock
Associate Director, Marketing
Revolution Medicines
 Lisa Graup
Lisa Graup
Executive Director of Marketing, Oncology
Revolution Medicines
 Kimberly Martinez
Kimberly Martinez
Senior Manager, Contract Optimization and Strategy Team - Clinical Operations
Revolution Medicines

More profiles

Discover additional public profiles from our index.

Tony Knight
Tony Knight
Director Product Quality Engineering
Inogen
 Adriann Kern
Adriann Kern
Director Clinical Research Operations
GeneDx
 Ryan Tracy
Ryan Tracy
Director of Operations
AngioDynamics
 Melody Noel
Melody Noel
Director of Inventory Management
Neogen Corporation
Unlock the full playbookSee exactly how to sell to Stephen. Free, 10 seconds.